Trending event
The Life Science Intellectual Property (IP) Playbook: What Life Science Companies Really Need to Know About IP
Print PDFJoin Nutter for a networking reception and life science panel discussion focusing on the importance of treating IP as a strategic business asset. Key takeaways include:
- Treating IP as a strategic business asset;
- Identifying overlooked IP landmines;
- Raising capital and preparing for exit; and
- Managing IP spend.
Don’t miss this opportunity to gain valuable perspective and connect with fellow life science business leaders.
Panelists:
- Jonathan Harris, Partner, Nutter
- Todd Brady, CEO, Aldeyra Therapeutics
- Romesh Subramanian, President and CEO, Marrow Therapeutics
Event details:
Wednesday, February 26, 2025
5:30-7:30 PM ET
Nutter
155 Seaport Blvd
Boston, MA 02210
